These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9866335)

  • 1. [Selective intraarterial application of Thienam and Vasoprostan in the treatment of purulent foot diseases in patients with diabetes mellitus].
    Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA
    Klin Khir; 1998; (8):53. PubMed ID: 9866335
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective intra-arterial use of small doses of thienam and vasaprostanin the treatment of suppurative diseases of the foot in patients with diabetes mellitus].
    Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA
    Vestn Khir Im I I Grek; 1998; 157(1):76-7. PubMed ID: 9611324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in the use of imipenem/cilastatin (thienam) in a surgical clinic].
    Briskin BS; Khachatrian NN; Nekrasova NI; Kuznetsov EV; Suplotova AA; Sosnovikova OG
    Khirurgiia (Mosk); 2000; (9):56-61. PubMed ID: 11026205
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic therapy for foot infections in diabetics.
    Hu XH; Markson LE; Abbott TA; Dasbach EJ; Berger ML
    Clin Infect Dis; 1997 Dec; 25(6):1488-90. PubMed ID: 9431413
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of thienam for the emergency antibacterial therapy of acute suppurative pyelonephritis].
    Pasiechnikov SP; Pohrebyns'kyĭ VM; Rudenko AV; Mitchenko MV
    Lik Sprava; 1997; (1):84-7. PubMed ID: 9221156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of antibiotic thienam in critical care patients].
    Mariutin PV; Uchvatkin VG
    Anesteziol Reanimatol; 1995; (4):67-8. PubMed ID: 7486202
    [No Abstract]   [Full Text] [Related]  

  • 7. [A trial of the clinical use of thienam in treating severe and life-threatening suppurative-septic complications].
    Grinev MV; Shapot IuB; Tsibin IuN; Gal'tseva IV; Chiritso BG
    Vestn Khir Im I I Grek; 1996; 155(4):54-6. PubMed ID: 8992722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of prostaglandin E1 and Naftidrofuryl in combined treatment of purulent-necrotic complications of the diabetic foot syndrome].
    Girka EI; Bazarinskaia ZI; Kravtsov EA
    Klin Khir; 2002; (11-12):21-2. PubMed ID: 12549263
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aprostan application in the treatment of the diabetic foot, atherosclerotic arterial lesions in the stage of critical ischemia].
    Mishalov VH; Seliuk VM; Cherviak VA; Litvinova NIu
    Klin Khir; 2001 Aug; (8):66-7. PubMed ID: 11794125
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbapenems in febrile neutropenic patients.
    Gaya H
    J Antimicrob Chemother; 1997 May; 39(5):667-8. PubMed ID: 9184371
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
    Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB
    Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peculiarities of the occurrence of soft tissue disorders and prospects of their closure in patients with diabetes mellitus].
    Driuk MF; Podpriatov SIe; Lisovets' VV; Rohachova VP
    Klin Khir; 2001 Aug; (8):14-6. PubMed ID: 11794097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thienam treatment in early postoperative period after pneumonectomy in patients with lung cancer].
    Potanin VP; Taziev RM; Sigal EI; Krasin VV; Khalimov ID; Potanin AV; Sigal RI; Latypov AG
    Khirurgiia (Mosk); 2001; (10):47-8. PubMed ID: 11763820
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vision in patients with the diabetic foot during the treatment with alprostan].
    Veselovskaia NN
    Klin Khir; 2001 Aug; (8):61-2. PubMed ID: 11794121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Imipenem-cilastatin cure of meningitis caused by Acinetobacter calcoaceticus].
    Sánchez JF; Sanz-Hospital J; Guerrero A; Martínez-Beltrán J; Quereda C
    Enferm Infecc Microbiol Clin; 1991 Oct; 9(8):512-3. PubMed ID: 1805958
    [No Abstract]   [Full Text] [Related]  

  • 17. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI; Fung CP; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of purulent and necrotic lesions of the lower extremities in patients with diabetes mellitus].
    Ohonovsky? VK; Podil?hak MD; Matskiv AS; Kravets SL; Tsemekhin BD
    Klin Khir (1962); 1993; (9-10):37-40. PubMed ID: 8158919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
    Larsen JW; Gabel-Hughes K; Kreter B
    Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activity of imipenem/cilastatin (thienam) against agents causing pyoseptic processes].
    Vasina TA; Kartavenko VI; Men'shikova ED; Shabanov AK; Mironov AV
    Khirurgiia (Mosk); 2002; (12):45-7. PubMed ID: 12522928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.